Organigram Global (OGI) Current Assets (2018 - 2025)
Organigram Global (OGI) posted quarterly Current Assets of $207.0 million for Q3 2025, up 7.7% year-over-year from $192.2 million in Q3 2024, and up 7.7% quarter-over-quarter from $192.2 million in Q3 2024.
Organigram Global (OGI) Current Assets (2018 - 2025) Analysis & Trends
Organigram Global (OGI) has reported Current Assets for 8 consecutive years, with $207.0 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Current Assets rose 7.7% year-over-year to $207.0 million; the TTM figure through Sep 2025 stood at $207.0 million (up 7.7% YoY), while the FY2025 annual figure was $207.0 million, up 7.7% from the prior year.
- Current Assets improved to $207.0 million in Q3 2025 per OGI's latest filing, from $192.2 million in the prior quarter.
- Across five years, Current Assets topped out at $209.7 million in Q3 2021 and bottomed at $116.3 million in Q3 2023.
- Historically, Current Assets has averaged $171.6 million across 5 years, with a median of $182.2 million in 2022.
- On a YoY basis, Current Assets climbed as much as 65.52% in 2021 and fell as far as 36.52% in 2021.
- Organigram Global's Current Assets stood at $209.7 million in 2021, then decreased by 17.92% to $172.1 million in 2022, then tumbled by 32.39% to $116.3 million in 2023, then surged by 65.21% to $192.2 million in 2024, then grew by 7.7% to $207.0 million in 2025.
- Business Quant data shows OGI's Current Assets at $207.0 million in Q3 2025, $192.2 million in Q3 2024, and $116.3 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Organigram Global | 151.93 Mn | 151.81 Mn | 28.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 207.02 Mn |
| Sep 30, 2024 | 192.22 Mn |
| Sep 30, 2023 | 116.35 Mn |
| Aug 31, 2022 | 172.09 Mn |
| Aug 31, 2021 | 209.66 Mn |
| Feb 28, 2021 | 132.25 Mn |
| Nov 30, 2020 | 208.38 Mn |
| Aug 31, 2020 | 126.66 Mn |
| May 31, 2020 | 116.30 Mn |
| Feb 29, 2020 | 208.33 Mn |
| Aug 31, 2019 | 148.47 Mn |
| May 31, 2019 | 232.47 Mn |
| Aug 31, 2018 | 155.21 Mn |